PARIS: AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said Thursday.Several countries have already altered their advice after previous research indicated that -- in a tiny number of cases -- thrombosis with thrombocytopenia syndrome (TTS) can be a possible side effect of Covid vaccines that use an adenovirus vector, or “engineered” virus, such as those from AstraZeneca and Johnson & Johnson.Thrombocytopenia produces potentially life-threatening blood clots with low levels of blood platelets -- the small cell fragments in our blood that prevent bleeding.The new stud
Hence then, the article about study confirms astrazeneca jab s higher risk of very rare clot was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Study confirms AstraZeneca jab’s higher risk of very rare clot )